ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 24 filers reported holding ELIEM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,938,263 | $5,097,632 | 4.68% |
| RA Capital Management | 13,150,849 | $34,586,733 | 0.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 121,110 | $318,519 | 0.10% |
| Atom Investors LP | 78,886 | $207,470 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 811,680 | $2,134,718 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,223 | $145,789 | 0.00% |
| Chicago Partners Investment Group LLC | 12,806 | $32,785 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 29,704 | $78,122 | 0.00% |
| NORTHERN TRUST CORP | 11,182 | $29,409 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 66,626 | $175,952 | 0.00% |
| STATE STREET CORP | 21,700 | $57,288 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 58,336 | $154,007 | 0.00% |
| MORGAN STANLEY | 1,709 | $4,495 | 0.00% |
| BlackRock Inc. | 31,311 | $82,347 | 0.00% |
| Qube Research & Technologies Ltd | 981 | $2,590 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,896 | $10,246 | 0.00% |
| ROYAL BANK OF CANADA | 56 | $0 | 0.00% |
| VANGUARD GROUP INC | 309,821 | $814,829 | 0.00% |
| UBS Group AG | 89 | $234 | 0.00% |
This page lists ELIEM THERAPEUTICS INC's shareholders in Q3 2023. To view ELIEM THERAPEUTICS INC's shareholder history, click here.